NICE rejects diabetes drug from Eli Lilly
The National Institute for Health and Care Excellence (NICE) in the UK, which among other things advises on medicines and monitors drug prices, will not yet recommend Eli Lilly’s Mounjaro (tirzepatide) for adults with diabetes.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.